bluebird bio Inc (LTS:0HOH)
$ 0.5004 0.0109 (2.23%) Market Cap: 96.39 Mil Enterprise Value: 342.75 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 29/100

bluebird bio Inc at Cowen Immuno-Oncology Next Summit Transcript

Nov 13, 2020 / 04:15PM GMT
Release Date Price: $45.65
Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Okay. We're just going to wait a couple of seconds to let the webcast kick in. And good morning, everybody, and thank you for joining us for our fourth annual IO Summit that coincides with SITC, which is obviously kicking off today.

I'm Yaron Werber, from the biotech team here at Cowen. It's a great pleasure to introduce bluebird, and both gentlemen here really need no introduction. Nick Leschly is the Chief Bluebird. And Philip Gregory, who's the Chief Scientific Officer.

Gentlemen, thanks so much for joining us. We appreciate it.

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Yaron, thanks for having us.

Yaron Benjamin Werber
Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst

Always a pleasure.

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Phil, you're on mute. So be careful.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot